Erythropoietin reduces the expression of myostatin in mdx dystrophic mice

Article English OPEN
D. Feder; M. Rugollini; A. Santomauro Jr; L.P. Oliveira; V.P. Lioi; R. dos Santos; L.G. Ferreira; M.T. Nunes; M.H. Carvalho; P.O. Delgado; A.A.S. Carvalho; F.L.A. Fonseca;

Made available in DSpace on 2016-01-24T14:38:03Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-11-01 Erythropoietin (EPO) has been well characterized as a renal glycoprotein hormone regulating red blood cell production by inhibiting apoptosis of erythroc... View more
  • References (40)
    40 references, page 1 of 4

    1. Rotter R, Menshykova M, Winkler T, Matziolis G, Stratos I, Schoen M, et al. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue. J Orthop Res 2008; 26: 1618-1626, doi: 10.1002/jor.20692.

    2. Lappin TR, Maxwell AP, Johnston PG. EPO's alter ego: erythropoietin has multiple actions. Stem Cells 2002; 20: 485-492, doi: 10.1634/stemcells.20-6-485.

    3. Scoppetta C, Grassi F. Erythropoietin: a new tool for muscle disorders? Med Hypotheses 2004; 63: 73-75, doi: 10.1016/ j.mehy.2003.12.044.

    4. Ogilvie M, Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000; 275: 39754-39761, doi: 10.1074/jbc.M004999200.

    5. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 1999; 126: 3597-3605.

    6. Heuberger JA, Cohen Tervaert JM, Schepers FM, Vliegenthart AD, Rotmans JI, Daniels JM, et al. Erythropoietin doping in cycling: Lack of evidence for efficacy and a negative riskbenefit. Br J Clin Pharmacol 20112; 1: 100-106.

    7. Vaziri ND. Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens 2001; 10: 633-637, doi: 10.1097/00041552-200109000-00013.

    8. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991; 1: 19-29, doi: 10.1016/0960-8966(91)90039-U.

    9. Merlini L, Gennari M, Malaspina E, Cecconi I, Armaroli A, Gnudi S, et al. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle Nerve 2012; 45: 796-802, doi: 10.1002/mus.23272.

    10. Jennekens FG, ten Kate LP, de Visser M, Wintzen AR. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Disord 1991; 1: 389-391, doi: 10.1016/0960-8966(91)90001-9.

  • Related Organizations (1)
  • Metrics